Scott R Plotkin Selected Research

B-Cell Lymphoma (Lymphoma, B Cell)

12/2023	Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cells.
1/2022	Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Scott R Plotkin Research Topics

Disease

55	Neoplasms (Cancer) 01/2024 - 02/2003
25	Neurofibromatosis 2 (Neurofibromatosis Type II) 06/2024 - 05/2009
18	Neurilemmoma (Schwannoma) 06/2024 - 07/2009
18	Acoustic Neuroma (Acoustic Neurinoma) 01/2023 - 10/2005
17	Schwannomatosis 11/2023 - 12/2012
16	Meningioma (Meningiomas) 01/2024 - 02/2008
16	Neurofibromatoses (Neurofibromatosis) 11/2023 - 05/2010
13	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 06/2010
11	Neurofibromatosis 1 (Neurofibromatosis Type I) 05/2024 - 02/2013
8	Pain (Aches) 02/2023 - 09/2012
6	Hearing Loss (Hearing Impairment) 01/2023 - 11/2015
5	Lymphoma (Lymphomas) 12/2023 - 09/2004
4	Plexiform Neurofibroma 11/2021 - 01/2020
4	Edema (Dropsy) 01/2021 - 11/2015
3	Neurofibroma 05/2024 - 10/2005
3	Rare Diseases (Rare Disease) 11/2023 - 10/2022
3	Carcinogenesis 01/2018 - 11/2007
2	B-Cell Lymphoma (Lymphoma, B Cell) 12/2023 - 01/2022
2	Tinnitus 01/2023 - 01/2018
2	Neurofibrosarcoma (MPNST) 11/2021 - 03/2015
2	Glioma (Gliomas) 11/2021 - 01/2020
2	Hypertension (High Blood Pressure) 01/2021 - 10/2016
2	Necrosis 03/2011 - 01/2011
1	Fever (Fevers) 12/2023
1	Leukoencephalopathies 10/2023
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2023
1	Chronic Pain 02/2023
1	COVID-19 01/2023
1	Leukemia 01/2021
1	Fatigue 01/2021
1	Hypothyroidism 01/2021
1	Pseudarthrosis (Pseudoarthrosis) 01/2021
1	Fibrosis (Cirrhosis) 01/2021

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 09/2023 - 06/2011
12	Bevacizumab (Avastin)FDA Link 01/2023 - 07/2009
10	Uvitex SWN (SWN)IBA 02/2023 - 01/2016
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 10/2005
7	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 06/2011
6	Mechanistic Target of Rapamycin Complex 1IBA 01/2024 - 08/2009
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2024 - 01/2020
4	Sirolimus (Rapamycin)FDA Link 01/2024 - 08/2009
4	Neurofibromin 2 (Merlin)IBA 09/2022 - 02/2008
4	Oxygen (Dioxygen)IBA 01/2021 - 06/2011
4	cediranib (AZD2171)IBA 01/2017 - 06/2010
3	Proteins (Proteins, Gene)FDA Link 11/2023 - 08/2009
3	Mechanistic Target of Rapamycin Complex 2IBA 01/2023 - 07/2015
3	Monoclonal AntibodiesIBA 10/2022 - 02/2003
3	Phosphotransferases (Kinase)IBA 01/2021 - 07/2015
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2017 - 06/2010
2	MTOR InhibitorsIBA 01/2024 - 07/2015
2	Methotrexate (Mexate)FDA LinkGeneric 10/2023 - 09/2004
2	Interleukin-6 (Interleukin 6)IBA 02/2023 - 01/2021
2	vistusertibIBA 01/2023 - 07/2015
2	Protons (Proton)IBA 01/2023 - 01/2022
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2021
2	Antineoplastic Agents (Antineoplastics)IBA 01/2018 - 05/2009
2	TOR Serine-Threonine KinasesIBA 01/2018 - 08/2009
2	Tyrosine Kinase InhibitorsIBA 01/2015 - 06/2010
2	ParaffinIBA 01/2013 - 07/2009
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2010 - 08/2008
1	sapanisertibIBA 01/2024
1	C-Reactive ProteinIBA 12/2023
1	Chimeric Antigen ReceptorsIBA 12/2023
1	Folic Acid (Vitamin M)FDA LinkGeneric 10/2023
1	HMGB1 Protein (HMG1)IBA 02/2023
1	ChemokinesIBA 02/2023
1	Epidermal Growth Factor (EGF)IBA 02/2023
1	Annexin A5IBA 01/2023
1	Hormones (Hormone)IBA 01/2023
1	Cytostatic AgentsIBA 01/2023
1	tanezumabIBA 10/2022
1	Analgesics (Analgesic Drugs)IBA 10/2022
1	Nerve Growth Factor (NGF)IBA 10/2022
1	tisagenlecleucelIBA 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	A-factor (Streptomyces)IBA 01/2022
1	selinexorIBA 01/2022
1	Angiotensin Receptor AntagonistsIBA 01/2021
1	Everolimus FDA Link 01/2021
1	LigandsIBA 01/2021
1	brigatinibIBA 01/2021
1	Fibroblast Growth Factor 7 FDA Link 01/2021
1	mirdametinibIBA 01/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	cabozantinibIBA 01/2021
1	Neuregulin-1 (Neuregulin 1)IBA 01/2021
1	NeuregulinsIBA 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	CytokinesIBA 01/2021
1	Losartan (Cozaar)FDA LinkGeneric 01/2021
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2021

Therapy/Procedure

43	Therapeutics 06/2024 - 02/2003
10	Drug Therapy (Chemotherapy) 01/2024 - 07/2008
10	Radiotherapy 01/2023 - 07/2008
4	Aftercare (After-Treatment) 01/2018 - 05/2010
2	Chemoprevention 10/2023 - 04/2014
2	Salvage Therapy 01/2023 - 12/2005
1	Induction Chemotherapy 10/2023
1	Operative Surgical Procedures 01/2021
1	Drug Tapering 01/2021